FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024497659> ?p ?o ?g. }

• W2024497659 endingPage "172" @default.
• W2024497659 startingPage "167" @default.
• W2024497659 abstract "The use of aromatase inhibitor (AI) in postmenopausal women with hormone receptor (HR)-positive early breast cancer (EBC) produces a deleterious effect on bone mass and an increase in fractures. Several studies using intravenous bisphosphonates have shown effective management of AI-induced bone loss. To determine whether a lower dosage in oral form combined with calcitriol can effectively manage AI-induced bone loss, we performed a randomized, double-blind, prospective, placebo-controlled 24-week trial with a combination of alendronate and 0.5-μg of calcitriol daily to HR-positive EBC patients. A total of 98 Korean postmenopausal women with HR-positive EBC who received daily AI, calcium and vitamin D were randomly assigned to 5-mg of alendronate and 0.5-μg of calcitriol (Maxmarvil®) or placebo groups. The bone mineral density (BMD) and turnover markers were measured. At week 24, the difference in lumbar BMD between the groups was 3.0% (p < 0.005). The increase in C-telopeptide after 24 weeks was significantly less in the Maxmarvil group compared to that in the placebo group (35.2 ± 17.5% vs. 109.8 ± 28.6%, p < 0.05). Our study demonstrates that a combination of 5-mg alendronate and 0.5-μg calcitriol is effective to prevent bone loss due to AI in Korean postmenopausal women with EBC." @default.
• W2024497659 created "2016-06-24" @default.
• W2024497659 creator A5012515136 @default.
• W2024497659 creator A5019576070 @default.
• W2024497659 creator A5041491639 @default.
• W2024497659 creator A5045580064 @default.
• W2024497659 creator A5047422769 @default.
• W2024497659 creator A5064674618 @default.
• W2024497659 date "2013-01-01" @default.
• W2024497659 modified "2023-10-06" @default.
• W2024497659 title "Efficacy of a combined alendronate and calcitriol agent (Maxmarvil^®) in Korean postmenopausal women with early breast cancer receiving aromatase inhibitor: a double-blind, randomized, placebo-controlled study" @default.
• W2024497659 cites W1529243395 @default.
• W2024497659 cites W1988565498 @default.
• W2024497659 cites W1998230148 @default.
• W2024497659 cites W2000519574 @default.
• W2024497659 cites W2004433352 @default.
• W2024497659 cites W2042626156 @default.
• W2024497659 cites W2054727157 @default.
• W2024497659 cites W2101213151 @default.
• W2024497659 cites W2139982528 @default.
• W2024497659 cites W2146194560 @default.
• W2024497659 cites W2146810449 @default.
• W2024497659 cites W2150904792 @default.
• W2024497659 cites W2158786144 @default.
• W2024497659 cites W2167469083 @default.
• W2024497659 cites W2322274315 @default.
• W2024497659 cites W2624963411 @default.
• W2024497659 doi "https://doi.org/10.1507/endocrj.ej12-0283" @default.
• W2024497659 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23064476" @default.
• W2024497659 hasPublicationYear "2013" @default.
• W2024497659 type Work @default.
• W2024497659 sameAs 2024497659 @default.
• W2024497659 citedByCount "18" @default.
• W2024497659 countsByYear W20244976592013 @default.
• W2024497659 countsByYear W20244976592014 @default.
• W2024497659 countsByYear W20244976592015 @default.
• W2024497659 countsByYear W20244976592016 @default.
• W2024497659 countsByYear W20244976592017 @default.
• W2024497659 countsByYear W20244976592018 @default.
• W2024497659 countsByYear W20244976592019 @default.
• W2024497659 countsByYear W20244976592020 @default.
• W2024497659 countsByYear W20244976592021 @default.
• W2024497659 countsByYear W20244976592022 @default.
• W2024497659 countsByYear W20244976592023 @default.
• W2024497659 crossrefType "journal-article" @default.
• W2024497659 hasAuthorship W2024497659A5012515136 @default.
• W2024497659 hasAuthorship W2024497659A5019576070 @default.
• W2024497659 hasAuthorship W2024497659A5041491639 @default.
• W2024497659 hasAuthorship W2024497659A5045580064 @default.
• W2024497659 hasAuthorship W2024497659A5047422769 @default.
• W2024497659 hasAuthorship W2024497659A5064674618 @default.
• W2024497659 hasBestOaLocation W20244976591 @default.
• W2024497659 hasConcept C121608353 @default.
• W2024497659 hasConcept C124490489 @default.
• W2024497659 hasConcept C126322002 @default.
• W2024497659 hasConcept C126894567 @default.
• W2024497659 hasConcept C134018914 @default.
• W2024497659 hasConcept C142724271 @default.
• W2024497659 hasConcept C168563851 @default.
• W2024497659 hasConcept C170033053 @default.
• W2024497659 hasConcept C202061045 @default.
• W2024497659 hasConcept C204787440 @default.
• W2024497659 hasConcept C27081682 @default.
• W2024497659 hasConcept C2776079296 @default.
• W2024497659 hasConcept C2776166826 @default.
• W2024497659 hasConcept C2776541429 @default.
• W2024497659 hasConcept C2776886416 @default.
• W2024497659 hasConcept C2778504769 @default.
• W2024497659 hasConcept C2779809032 @default.
• W2024497659 hasConcept C2991744798 @default.
• W2024497659 hasConcept C530470458 @default.
• W2024497659 hasConcept C71924100 @default.
• W2024497659 hasConcept C90924648 @default.
• W2024497659 hasConceptScore W2024497659C121608353 @default.
• W2024497659 hasConceptScore W2024497659C124490489 @default.
• W2024497659 hasConceptScore W2024497659C126322002 @default.
• W2024497659 hasConceptScore W2024497659C126894567 @default.
• W2024497659 hasConceptScore W2024497659C134018914 @default.
• W2024497659 hasConceptScore W2024497659C142724271 @default.
• W2024497659 hasConceptScore W2024497659C168563851 @default.
• W2024497659 hasConceptScore W2024497659C170033053 @default.
• W2024497659 hasConceptScore W2024497659C202061045 @default.
• W2024497659 hasConceptScore W2024497659C204787440 @default.
• W2024497659 hasConceptScore W2024497659C27081682 @default.
• W2024497659 hasConceptScore W2024497659C2776079296 @default.
• W2024497659 hasConceptScore W2024497659C2776166826 @default.
• W2024497659 hasConceptScore W2024497659C2776541429 @default.
• W2024497659 hasConceptScore W2024497659C2776886416 @default.
• W2024497659 hasConceptScore W2024497659C2778504769 @default.
• W2024497659 hasConceptScore W2024497659C2779809032 @default.
• W2024497659 hasConceptScore W2024497659C2991744798 @default.
• W2024497659 hasConceptScore W2024497659C530470458 @default.
• W2024497659 hasConceptScore W2024497659C71924100 @default.
• W2024497659 hasConceptScore W2024497659C90924648 @default.
• W2024497659 hasIssue "2" @default.
• W2024497659 hasLocation W20244976591 @default.
• W2024497659 hasLocation W20244976592 @default.
• W2024497659 hasOpenAccess W2024497659 @default.

• next